
The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC. …

Linda Armstrong, Global Head, Respiratory Development Unit at Novartis.

In a saddening turn of events, San Francisco-based FibroGen has announced that Thomas B Neff, its Chief Executive Officer and …

UK-based GW Pharma has suffered a setback in its home country after drug watchdog NICE chose not to recommend NHS …

The Royal College of Obstetricians and Gynaecologists (RCOG) have called for action from government and pharmaceutical companies to adress ongoing …

A judge in Oklahoma has said that Johnson & Johnson must pay $572 million for the part it played in …
By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in …

The US Department of Health and Human Services (HHS) has said it will fund the production of MSD’s investigational Ebola …

AbbVie’s Skyrizi (risankizumab) has been awarded a positive recommendation from UK drug watchdog NICE, meaning that the IL-23 inhibitor will …

A generic version of Mylan’s EpiPen, manufactured by Teva, is now available for children weighing between 15kg and 30kg in …

New data have emerged illustrating that AstraZeneca’s anti-CTLA4 antibody Imfinzi (durvalumab) failed to meet its primary endpoint when used in …

NHS England is to fund Roche and Chugai Pharma UK’s haemophilia drug Hemlibra, for people with sever congenital haemophilia A …

Dr Brian Kaspar, the Novartis exec pushed out of AveXis over the Zolgensma data scandal, has said in a statement …

A man from Walnut, California has been sentenced to eight years and four months in federal prison for illegally importing …

The FDA has declined to approve Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) drug, citing safety concerns including risk of infection …